Haas NB - Search Results

1

Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805.

Haas NB, Manola J, Ky B, Flaherty KT, Uzzo RG, Kane CJ, Jewett M, Wood L, Wood CG, Atkins MB, Dutcher JJ, Wilding G, DiPaola RS. Haas NB, et al. Clin Cancer Res. 2015 Sep 15;21(18):4048-54. doi: 10.1158/1078-0432.CCR-15-0215. Epub 2015 May 12. Clin Cancer Res. 2015. PMID: 25967143 Free PMC article. Clinical Trial.

2

Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.

Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL. Langer CJ, et al. Cancer J Sci Am. 1996 Mar-Apr;2(2):99-105. Cancer J Sci Am. 1996. PMID: 9166507 Clinical Trial.

3

Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancer.

Haas NB, Manola J, Hudes G, Citrin DL, Kies MS, Davis TE; Eastern Cooperative Oncology Group Study PH882. Haas NB, et al. Am J Clin Oncol. 2000 Dec;23(6):589-92. doi: 10.1097/00000421-200012000-00012. Am J Clin Oncol. 2000. PMID: 11202803 Clinical Trial.

4

Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study.

Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR. Haas NB, et al. Clin Cancer Res. 2003 Jan;9(1):109-14. Clin Cancer Res. 2003. PMID: 12538458 Clinical Trial.

5

The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician.

Uzzo RG, Cairns P, Al-Saleem T, Hudes G, Haas N, Greenberg RE, Kolenko V. Uzzo RG, et al. Urol Clin North Am. 2003 Aug;30(3):423-36. doi: 10.1016/s0094-0143(03)00021-1. Urol Clin North Am. 2003. PMID: 12953746 Review.

6

Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.

Haas NB, Giantonio BJ, Litwin S, Minniti CJ Jr, Fox S, Yeslow G, Reilly R, Nahum K, Greenberg R, Halbherr T, Hudes GR. Haas NB, et al. Cancer. 2003 Nov 1;98(9):1837-41. doi: 10.1002/cncr.11734. Cancer. 2003. PMID: 14584064 Free article. Clinical Trial.

7

Adjuvant therapy for high-risk renal cell carcinoma patients.

Kunkle DA, Haas NB, Uzzo RG. Kunkle DA, et al. Among authors: haas nb. Curr Urol Rep. 2007 Jan;8(1):19-30. doi: 10.1007/s11934-007-0017-5. Curr Urol Rep. 2007. PMID: 17239313 Review.

8

Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology Group.

Dreicer R, Li S, Manola J, Haas NB, Roth BJ, Wilding G; Eastern Cooperative Oncology Group. Dreicer R, et al. Among authors: haas nb. Cancer. 2007 Aug 15;110(4):759-63. doi: 10.1002/cncr.22839. Cancer. 2007. PMID: 17594721 Free article. Clinical Trial.

9

Tyrosine kinase inhibitors and anti-angiogenic therapies in kidney cancer.

Haas NB, Uzzo RG. Haas NB, et al. Curr Treat Options Oncol. 2007 Jun;8(3):211-26. doi: 10.1007/s11864-007-0031-3. Curr Treat Options Oncol. 2007. PMID: 17712534 Review.

10

Targeted therapies for kidney cancer in urologic practice.

Haas NB, Uzzo RG. Haas NB, et al. Urol Oncol. 2007 Sep-Oct;25(5):420-32. doi: 10.1016/j.urolonc.2007.05.009. Urol Oncol. 2007. PMID: 17826664 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters